A different first-choice drug in the medical management of patent ductus arteriosus: oral paracetamol


Yurttutan S., Oncel M. Y., Arayici S., Uras N., Altug N., ERDEVE Ö., ...More

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, vol.26, no.8, pp.825-827, 2013 (SCI-Expanded) identifier identifier identifier

Abstract

Background and objectives: Patent ductus arteriosus (PDA) is a significant cause of morbidity and mortality in preterm infants. This case series was conducted to investigate the usefulness of paracetamol as a first choice for the treatment of PDA in preterm infants.